Dr. Stuart (Stu) Mair has over 16 years of experience delivering exploratory clinical studies in the contract research organization (CRO) industry. He has delivered over 100 first-in-human (FIH) studies and is an expert in the design and implementation of exploratory clinical trials from FIH to proof of concept (POC) in patient groups with pharmacodynamic (PD) biomarkers. Stuart has advised clients on multiple study types, from simple pharmacokinetic (PK), bioequivalence (BE), and characterization studies to complex and flexible designs with multiple portions delivered under a single protocol. 

Prior to joining Quotient Sciences, Stuart was the Medical Director at Charles River Laboratories. He holds a MBChB (Bachelor of Medicine and Bachelor of Surgery) degree and DRCOG (Diploma of the Royal College of Obstetricians and Gynaecologists), DCPSA (Diploma in Clinical Pharmacology of the Society of Apothecaries), and MFPM (Membership of the Faculty of Pharmaceutical Medicine) credentials from the University of Aberdeen in the UK.